Hypercoagulability
11
1
1
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
18.2%
2 terminated out of 11 trials
66.7%
-19.8% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
Effect of Phototherapy With Exercise on Coagulation in Elderly
AntiCoagulation Tracking InterVention and Evaluation
Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery
Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT
ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin